IPO Premiums
IPO calendar
MPMUKKAListed

Mukka Proteins Limited

Book Built Issue IPO · NSE, BSE

Price band
₹26 - ₹28
Lot size
535 shares
Issue amount
₹224 cr
Total subscription
136.89×
Current price₹29.53
Listing price ₹40
Watch live price ↗
Opens
29 Feb 2024
Closes
4 Mar 2024
Allotment
6 Mar 2024
Listing
7 Mar 2024

Offer at a glance

Issue overview

Issue size
8,00,00,000 shares
Face value
₹1 Per Equity Share
Minimum investment
₹13,910
Fresh issue
₹224 cr
Offer for sale
₹0 cr
Registrar
Cameo Corporate Services Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,980
Issue type
Book Built Issue IPO
Shares before issue
22,00,00,000
Shares after issue
30,00,00,000

Lot sizes

CategoryLotsSharesAmount
RETAIL1535₹14,980
sHNI147,490₹2,09,720
bHNI5735,845₹10,03,660

Share reservation

Retail35%
NII(HNI)15%
QIB20%

Subscription & GMP

Subscription by category

Total subscribed136.89×

Missing multiples are calculated from bids and offered shares when available.

QIB189.28×
NIB250.26×
HNIs(10L +)254.15×
HNIs (2-10L)242.48×
RETAIL58.36×

GMP history

017.53512 Mar: ₹3519 Nov: ₹35
12 Mar₹3519 Nov

Application-wise demand

CategoryReserved applicationsApplied applications
——

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs44.88,479.89
RETAIL78.44,575.58
NIB33.68,408.64
HNIs 2+11.22,715.73
HNIs 10+22.45,692.91

Financial performance

Company financials

in ₹ Crore · Reported periods may include interim results.

Revenue & profitin ₹ Crore
05001,0001,500Mar-21 · Revenue: 609.95Mar-21 · Profit after tax: 11.01Mar-21Mar-22 · Revenue: 776.15Mar-22 · Profit after tax: 25.82Mar-22Mar-23 · Revenue: 1,183.8Mar-23 · Profit after tax: 47.53Mar-23Sep-23 · Revenue: 612.88Sep-23 · Profit after tax: 32.98Sep-23
RevenueProfit after tax

Key performance indicators

Metric202320222021
EPS21.10.41
ROE36.713017.37
ROCE17.6213.865.86
RONW34.1927.7513.91
PRE IPO(PE)4.7800
POST IPO(PE)12.9600

Values and labels as reported in the issue data.

Company information

Company profile

Mukka Proteins Limited, founded in March 2003, is a leading manufacturer of fish protein products, supplying fish meal, fish oil, and fish soluble paste to the aqua feed, poultry feed, and pet food industries. With a global footprint spanning over 10 countries, including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam, the company ensures high-quality production through its six strategically located coastal facilities in India and Oman, along with three blending plants and five storage facilities in India. Certified by NQA and UKAS for ISO 22000:2018 and ISO 9001:2015, Mukka Proteins upholds stringent quality and food safety standards. Additionally, the company leverages contractual partnerships with third-party manufacturing facilities in Karnataka (Sasihithlu and Udupi) and Maharashtra (Taloja and Ratnagiri). Supported by a dedicated workforce of 385 employees across technical, administrative, and managerial roles, Mukka Proteins continues to strengthen its position as a key player in the global fish protein manufacturing industry through excellence in operations, adherence to international standards, and strategic expansion.

Strengths

  • Market Leadership: A leading manufacturer and exporter in fish protein products with a global reach.
  • Customer Loyalty: Established relationships with international clients ensure consistent demand.
  • Strategic Facility Locations: Proximity to coastlines in India and Oman allows cost-effective and efficient operations.
  • High Entry Barriers: Significant capital and regulatory requirements limit new competition, protecting market share.
  • Financial Stability: Strong revenue growth and healthy margins support sustainable expansion.

Risk factors

  • Legal & Regulatory Risks: Ongoing legal proceedings, including environmental and foreign exchange violations, may impact operations and reputation.
  • Dependence on Approvals: Business operations rely on obtaining and renewing various regulatory approvals, posing a compliance risk.
  • Financial Impact of Legal Challenges: Legal disputes involving the Promoter Director could lead to financial strain and investor concerns.
  • Uncertainty in Fund Utilization: Planned use of proceeds for working capital is based on estimates, risking potential misallocation.
  • Operational Disruptions: Non-compliance with regulations could result in fines, legal liabilities, or business interruptions.

Promoters

Kalandan Mohammed Haris

Kalandan Mohammad Arif

Kalandan Mohammed Althaf

Registrar & documents

Lead manager

Fedex Securities Private Limited

Registered office

Mukka Corporate House, Door, No. 18-2-16/4, First Cross, NG Road, Attavar Dakshina, Kannada, Mangaluru – 575 001

+918244252889

[email protected]Company website ↗

Understanding MUKKA IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.